RXRX
#2084
Recursion Pharmaceuticals, Inc. - Class A Common Stock
3.3 4 USD
-0.03%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.91%
Monthly Change
+8.09%
6 month change
-4.02%
Year Change
-27.23%
Previous Close
3.4 4
Open
3.3 4
Low
3.3 4
High
3.3 4
Volume
112
Financials
- Market Capitalization 1.79 B
- Employee 600
- Founded 2013
- CEO Najat Khan
- Website www.recursion.com
- Headquarter Delaware, United States
- FIGI BBG00PQ4XJ45
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.84
Price to sales ratio
24.5
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2076 |  NTLA Intellia Therapeutics, Inc. - Common Stock | 12.87 USD | -1.83% | +2.14% | +15.63% | -6.20% | 1.80 B USD | ||
| 2083 |  FTRE Fortrea Holdings Inc. - Common Stock | 18.81 USD | -0.27% | +3.69% | +0.05% | +95.12% | 1.79 B USD | ||
| 2106 |  SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 19.54 USD | -3.08% | -0.76% | +0.88% | +18.42% | 1.74 B USD | ||
| 2110 |  GHRS GH Research PLC - Ordinary Shares | 27.94 USD | -2.48% | -0.92% | -1.96% | +97.32% | 1.73 B USD |
Frequently asked questions about Recursion Pharmaceuticals, Inc. Class A Common Stock
What is the Recursion Pharmaceuticals, Inc. Class A Common Stock stock price today?
The current price of Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) is 3.34. Over the past 24 hours, the stock has changed by -2.91%. Follow the RXRX chart for real-time price dynamics.
What is the stock ticker of Recursion Pharmaceuticals, Inc. Class A Common Stock?
Recursion Pharmaceuticals, Inc. Class A Common Stock trades under the ticker RXRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Recursion Pharmaceuticals, Inc. Class A Common Stock stock going up?
RXRX has changed by -2.05% over the last week, +8.09% over the last month, and -27.23% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Recursion Pharmaceuticals, Inc. Class A Common Stock?
Recursion Pharmaceuticals, Inc. Class A Common Stock currently has a market capitalization of 1.79 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Recursion Pharmaceuticals, Inc. Class A Common Stock earnings last quarter?
Last quarter, Recursion Pharmaceuticals, Inc. Class A Common Stock reported earnings of -0.25 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Recursion Pharmaceuticals, Inc. Class A Common Stock revenue for the last quarter?
Recursion Pharmaceuticals, Inc. Class A Common Stock reported quarterly revenue of 7.67 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Recursion Pharmaceuticals, Inc. Class A Common Stock net income for the last quarter?
Recursion Pharmaceuticals, Inc. Class A Common Stock reported net income of -131 M for the last quarter. The previous quarter showed -117.5 M, which means net income changed by -11.49%.
How many employees does Recursion Pharmaceuticals, Inc. Class A Common Stock have?
As of the latest available data, Recursion Pharmaceuticals, Inc. Class A Common Stock has 600 employees. Workforce size can provide additional context about the company's scale and operations.
What is Recursion Pharmaceuticals, Inc. Class A Common Stock EBITDA?
Recursion Pharmaceuticals, Inc. Class A Common Stock EBITDA is -116.8 M, and its EBITDA margin is -1 522.83%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Recursion Pharmaceuticals, Inc. Class A Common Stock stock?
You can buy Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Recursion Pharmaceuticals, Inc. Class A Common Stock stock?
Investing in Recursion Pharmaceuticals, Inc. Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RXRX chart and related analysis on metatrader.com as part of your research.